Comparison
Bromantane vs Curcumin
Side-by-side of Bromantane and Curcumin. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Bromantane
Bromantane, the Russian nootropic sold as Ladasten (ADK-709), acts on dopamine to cut fatigue and anxiety without classical stimulant rebound.
Curcumin
Curcumin supplement guide: turmeric extract at 500-1000 mg/day, piperine and Meriva for absorption, evidence in joint inflammation and mood.
Effects at a glance
Bromantane
- •Russian RCT base (Voznesenskaya 2010, n=728) supports 50 mg daily for asthenia and fatigue over 4 weeks
- •Atypical actogenic mechanism: induces tyrosine hydroxylase rather than direct monoamine release
- •Subjective profile is anxiolytic plus mildly motivating, distinct from classical stimulants
- •Long half-life of around 11 hours supports once-daily morning dosing
- •WADA-banned since 1996; relevant for tested athletes
- •Western evidence base is thin; most published trials are Russian-language and not independently replicated
Curcumin
- •Reduces osteoarthritis knee pain comparable to ibuprofen at 1500 mg/day enhanced formulation
- •Modest antidepressant effect (SMD ~0.34) as monotherapy or SSRI adjunct in major depression
- •Standard curcumin has ~3% bioavailability; Meriva, BCM-95, Theracurmin shift absorption 5-30 fold
- •Inhibits NF-kB and COX-2; reduces hs-CRP, IL-6, TNF-alpha in chronic inflammation
- •Antiplatelet effect at higher doses; meaningful interaction with warfarin and DOACs
- •Iron chelation can contribute to deficiency in already-marginal patients
Side-by-side
| Attribute | Bromantane | Curcumin |
|---|---|---|
| Category | nootropic | natural |
| Also known as | Ladasten, ADK-709, N-(4-bromophenyl)adamantan-2-amine | turmeric extract, diferuloylmethane |
| Half-life (hr) ↗ | 11 | 7 |
| Typical dose (mg) ↗ | 75 | 500 |
| Dosing frequency | daily, morning | 1 to 2 times daily with meals |
| Routes | oral | oral |
| Onset (hr) | 3 | 2 |
| Peak (hr) | 168 | 4 |
| Molecular weight | 280.21 | 368.38 |
| Molecular formula | C16H20BrN | C21H20O6 |
| Mechanism | Indirect dopaminergic and serotonergic actogenic activity via induction of tyrosine hydroxylase and selective increases in serotonin synthesis in hippocampus and hypothalamus. | Inhibits NF-kB transcription factor, COX-2, and lipoxygenase; activates AMPK and Nrf2; modulates JAK-STAT and PI3K-Akt kinase signaling. Pleiotropic anti-inflammatory and antioxidant effects. |
| Legal status | Approved in Russia (Ladasten); unscheduled and unapproved in US, EU, UK | Dietary supplement (global) |
| WADA status | banned | allowed |
| DEA / Rx | Not scheduled in the US | Not scheduled |
| Pregnancy | Not recommended | Culinary turmeric is safe; supplemental curcumin best avoided in pregnancy |
| CAS | 87913-26-6 | 458-37-7 |
| PubChem CID | 9576456 | 969516 |
| Wikidata | Q4093816 | Q312266 |
Safety profile
Bromantane
Common side effects
- mild GI upset
- headache
- skin rash
- occasional insomnia at higher doses
Contraindications
- pregnancy
- lactation
- severe hepatic impairment
- severe renal impairment
- pediatric use
Interactions
- MAOIs: theoretical additive dopaminergic and serotonergic activity(major)
- levodopa and dopamine agonists: additive dopaminergic activity(moderate)
- SSRIs and other serotonergic drugs: theoretical serotonergic additivity(moderate)
- classical stimulants: theoretical additive activity, undocumented(moderate)
Curcumin
Common side effects
- nausea
- diarrhea
- dyspepsia
- yellow stool (benign)
Contraindications
- active gallstones (curcumin stimulates gallbladder contraction)
- severe biliary obstruction
- scheduled elective surgery (discontinue 1-2 weeks prior)
Interactions
- warfarin and DOACs: additive antiplatelet and anticoagulant effects; meaningful bleeding risk at 1000+ mg/day(major)
- aspirin and NSAIDs: additive antiplatelet effect(moderate)
- tacrolimus and cyclosporine: CYP3A4 and P-gp modulation may alter drug levels(moderate)
- iron supplements: curcumin chelates iron; can contribute to deficiency in marginal patients(moderate)
- chemotherapy agents: potential interference with multiple agents; coordinate with oncology team(major)
Which Should You Take?
Curcumin comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Bromantane is the right call when one of the conditionals below applies.
- → If your priority is focus or working memory, pick Bromantane.
- → If your priority is fatigue resistance, pick Bromantane.
- → If your priority is post-training recovery, pick Curcumin.
- → If your priority is healthspan extension, pick Curcumin.
Edge case: If you want to avoid controlled substance, Curcumin is the more accessible choice.
Default choice: Curcumin. Lower friction to source, and broader goal coverage. Reach for Bromantane only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Bromantane and Curcumin?
Bromantane and Curcumin differ in category (nootropic vs natural), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Bromantane or Curcumin?
Bromantane half-life is 11 hours; Curcumin half-life is 7 hours.
Can you stack Bromantane with Curcumin?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper